Page last updated: 2024-12-09

bedt-ttf

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BEDT-TTF: a deuterated-BEDT-TTF superconductor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID633432
SCHEMBL ID53914
MeSH IDM0448027

Synonyms (20)

Synonym
bis(ethylenedithio)tetrathiafulvalene, 98%
bis(ethylenedithio)tetrathiafulvalene
66946-48-3
B1200
bedt-ttf
2-(5,6-dihydro-[1,3]dithiolo[4,5-b][1,4]dithiin-2-ylidene)-5,6-dihydro-[1,3]dithiolo[4,5-b][1,4]dithiine
AKOS004910070
FT-0623066
SCHEMBL53914
J-200088
LZJCVNLYDXCIBG-UHFFFAOYSA-N
bis(ethylenedithiolo)tetrathiafulvalene
mfcd00059710
bis(ethylenedithio)tetrathiafulvalene (bedt-ttf)
DTXSID70348249
bis(ethylenedithio)tetrathiafulvalene [organic electronic material]
bis(ethylenedithio)tetrathiafulvalene, [organic electronic material]
T71200
1,3-dithiolo[4,5-b][1,4]dithiin, 2-(5,6-dihydro-1,3-dithiolo[4,5-b][1,4]dithiin-2-ylidene)-5,6-dihydro-
Z56796171
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.36 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]